NCT00314275

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System

Evaluation of Pharmacokinetics (PK) and Safety of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: Medtronic Vascular · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the pharmacokinetics (PK) and safety associated with ABT-578 administered using the Medtronic Endeavor Drug Eluting Coronary Stent system in the treatment of single de novo lesions in native coronary arteries between 2.5 - 3.5 mm in diameter.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	Coronary Artery Stenting	Drug eluting stent
DEVICE	Endeavor	Drug eluting stent

Timeline

• Start date: 2006-01-01
• Primary completion: 2006-05-01
• Completion: 2011-08-01
• First posted: 2006-04-13
• Last updated: 2012-04-20

Locations

1 site across 1 country: United States